Dave Named Wellcome Clinical Distinguished Professor of Medicine (2022)

Duke Cancer Institute member Sandeep Dave, MD, MS, has been named the Wellcome Clinical Distinguished Professor of Medicine.

Dave is a physician-scientist and professor in the Department of Medicine and Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine. He works at the interface of genomic and computing technologies to investigate lymphoma and other blood cancers.

His group has made numerous important observations, including characterizing the role of genetic drivers in different cancers, and has enabled a comprehensive understanding of the molecular origins of different leukemias and lymphomas and informed new ways to treat them.

Dave has been the recipient of honors including induction into the American Society for Clinical Investigation, the honor society for physician-scientists; election to the scientific advisory board of the Lymphoma Research foundation; and membership on the editorial board of the World Health Organization, numerous major biomedical journals, and the NIH study section on cancer genetics.

He is also the recipient of career awards from the Doris Duke Foundation and American Cancer Society.

Subgroup analysis improves understanding of frontline DLBCL options (Targeted Oncology)